| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |